Cilostazol

Cilostazol is a selective phosphodiesterase-3 inhibitor with antiplatelet and vasodilatory properties, used for symptomatic relief of intermittent claudication in peripheral arterial disease. Simson Pharma's Cilostazol reference standard and impurities support compendial testing for this peripherally acting vasodilator.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Cilostazol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Cilostazol
Cilostazol Related Compound B
Cilostazol Related Compound A
Cilostazol Related Compound C
Cilostazol Impurity 1
Cilostazol Impurity 20
Cilostazol Impurity 5
4`-trans-Hydroxycilostazol
Cilostazol Impurity 2
Cilostazol Impurity 7
3-chloro-N-(4-methoxyphenyl)propanamide
Cilostazol Impurity 15
Cilostazol Impurity 16
Cilostazol Impurity 6
Cilostazole Dimer
Cilostazol Impurity 6
N-Nitroso Cilostazol
Cilostazol Impurity 11
Cilostazol Impurity 3

Isotope Labelled Compounds

Cilostazol-D4
Cilostazol-D11